Pharmacological Intervention to Prevent Muscle Contractures

##plugins.themes.bootstrap3.article.main##

Marianne Emmert
Roger Cornwall
Kritton Shay-Winkler
Qing Goh

Abstract

By Marianne Emmert, Medical Sciences; Roger Cornwall, Cincinnati Children's Hospital Medical Center; Kritton Shay-Winkler, Cincinnati Children's Hospital Medical Center


Advisor: Qing Goh


Abstract: In Summer 2019, I was given the opportunity to work as a RaMP Student Researcher in the Cornwall Laboratory at Cincinnati ChildrenÕs Hospital Medical Center. Here, we study cerebral palsy and neonatal brachial plexus injury, which are the two most common causes of paralysis in children. Specifically, our laboratory is focused on identifying effective treatments for the debilitating muscle contractures that ensue. These contractures severely impair function and mobility in the affected limbs and are currently incurable. To address this, one of our major projects is to determine the efficacy of the FDA-approved drug, bortezomib, for preventing contractures in a mouse model of neonatal brachial plexus injury. Besides assisting with drug preparations and injections, my main responsibility in this project was to investigate the long-term effects of this drug on skeletal muscle growth and development.
This enriching experience has benefited me both professionally and personally. As a Pre- Medical student, the RaMP program offered me my first hands-on experience working in a biomedical research laboratory. Furthermore, this experience has opened many doors for me as I have been presented with opportunities to contribute to a scientific manuscript and to present my findings at a Developmental Biology conference. Personally, RaMP has been one of the my most impactful experiences at the University of Cincinnati. This experience showed me that my scientific contributions as a student have the potential to directly impact another personÕs life.

##plugins.themes.bootstrap3.article.details##

Section
Classic Poster (9:45-11:45 AM)